Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001129928-09-000021
Filing Date
2009-04-09
Accepted
2009-04-08 19:00:00
Documents
13
Period of Report
2009-04-08

Document Format Files

Seq Description Document Type Size
1 6K FORM form-6k.htm 6-K 24367
2 FORM OF PROXY AND 2008 ANNUAL REPORT proxy.htm EX-99.1 2101198
3 img3_rm.jpg GRAPHIC 3049
4 img4_rm.jpg GRAPHIC 1640
5 img5_rm.jpg GRAPHIC 2212
6 img6_rm.jpg GRAPHIC 2187
7 img7_rm.jpg GRAPHIC 2200
8 img9_rm.jpg GRAPHIC 486
9 img1_mh.jpg GRAPHIC 73910
10 img2_mh.jpg GRAPHIC 25158
11 img20.jpg GRAPHIC 2046
12 img10_rm.jpg GRAPHIC 54737
13 img8_rm.jpg GRAPHIC 463
  Complete submission text file 0001129928-09-000021.txt   2359864
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 09740855
SIC: 2834 Pharmaceutical Preparations